A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Olanzapine/samidorphan (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Acronyms ENLIGHTEN-2
- Sponsors Alkermes plc
- 04 May 2017 According to an Alkermes plc media release, data from this trial are expected in mid-2018.
- 28 Mar 2016 Study design will be presented at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference 2016, according to an Alkermes plc media release.
- 10 Feb 2016 Status changed from planning to recruiting, according to an Alkermes plc media release.